Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Repaglinide (2mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Repacept 2 Tablet containing Repaglinide is used for the management of type 2 diabetes mellitus. It helps in controlling blood sugar levels, especially after meals.
Repaglinide works by stimulating the pancreas to release insulin rapidly, which helps reduce postprandial blood glucose levels effectively.
The tablet is widely prescribed in diabetic care for glycemic management and is often used in combination therapy, leading to consistent demand and repeat usage.
With increasing prevalence of diabetes and growing demand for effective blood sugar control therapies, this product offers strong business potential for retailers and distributors. Its chronic therapy usage, steady prescription demand, and broad acceptance in diabetic care make it a reliable product for consistent sales and growth in the anti-diabetic segment.
Some patients may experience hypoglycemia, headache, dizziness, nausea, or mild gastrointestinal discomfort. Rarely, allergic reactions or liver function abnormalities may occur and require medical attention.
Repacept 2 Tablet is indicated for the management of type 2 diabetes mellitus, particularly for controlling post-meal blood sugar spikes. It helps regulate blood glucose levels, improve insulin response, and reduce the risk of diabetes-related complications when combined with proper diet and exercise.
This medicine should be used under medical supervision. It is usually taken before meals, and skipping meals after taking the tablet may increase the risk of hypoglycemia. Regular blood glucose monitoring is recommended during therapy.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Dapagliflozin (10mg) + Metformin (500mg) ER + Sitagliptin (100mg) Tablet
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg Tablets
Composition : Dapagliflozin 5mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Sitagliptin Phosphate I.P. 100mg + Dapagliflozin Propanediol U.S.P. 10mg Tablets
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Repacept 2 Tablet, containing Repaglinide 2mg, has strong demand in the diabetes care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-diabetic and metabolic disorder portfolios.
Why should medical distributors include Repacept 2 Tablet in their product range?
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Repacept 2 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady diabetic prescription demand, reliable supply chain support, good margins, and professional assistance when partnering for Repacept 2 Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Repacept 2 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.